+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cholesterol Testing Products & Services Market (2022-2027) by Age Group, Type of Customer, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 185 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5669520

The advanced Techniques in mass spectrometry, gas chromatography and enzymatic assays are proliferating the demand of Cholesterol Testing Products

The Global Cholesterol Testing Products & Services Market is estimated to be USD 20.98 Bn in 2022 and is expected to reach USD 28.6 Bn by 2027, growing at a CAGR of 6.39%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Market Segmentations

The Global Cholesterol Testing Products & Services Market is segmented based on Age Group, Type of Customer, and Geography.
  • By Age Group, the market is classified into Adults, Geriatric, and Pediatric.
  • By Type of Customer, the market is classified into Diagnostic Centers, Government Agencies, and Physicians/Providers and Hospitals.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Blooms The Chemist, Boston Heart Diagnostics Corp., Bypass Pharmacy, Inc., Cell Biolabs Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Jant Pharmacal Corp., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Cholesterol Testing Products & Services Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Cholesterol Testing Products & Services Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cholesterol Testing Products & Services Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cholesterol Testing Products & Services Market

What is the estimated value of the Global Cholesterol Testing Products & Services Market?

The Global Cholesterol Testing Products & Services Market was estimated to be valued at $20.98 Billion in 2022.

What is the growth rate of the Global Cholesterol Testing Products & Services Market?

The growth rate of the Global Cholesterol Testing Products & Services Market is 6.3%, with an estimated value of $28.6 Billion by 2027.

What is the forecasted size of the Global Cholesterol Testing Products & Services Market?

The Global Cholesterol Testing Products & Services Market is estimated to be worth $28.6 Billion by 2027.

Who are the key companies in the Global Cholesterol Testing Products & Services Market?

Key companies in the Global Cholesterol Testing Products & Services Market include Abbott Laboratories, Blooms The Chemist, Boston Heart Diagnostics Corp., Bypass Pharmacy, Inc., Cell Biolabs, Inc., Eurofins Scientific SE, F. Hoffmann, La Roche Ag, Jant Pharmacal Corp. and Kays Medical, Ltd..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Prevalence of High Cholesterol and Cardiac Diseases
4.1.2 Growing Obese and Geriatric Population
4.1.3 Increasing Consumption of Alcohol and Smoking
4.2 Restraints
4.2.1 Stringent Regulatory Policies
4.2.2 Limited Availability of Diagnostic Laboratories and Lack of Skilled Professionals
4.3 Opportunities
4.3.1 Technological Development in Cholesterol Testing Systems
4.3.2 Increasing Awareness and Adoption of Preventive Healthcare
4.4 Challenges
4.4.1 Increasing Adoption of Home or Self-Testing
4.4.2 Development of Noninvasive Cholesterol Testing Methods
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Cholesterol Testing Products & Services Market, By Age Group
6.1 Introduction
6.2 Adults
6.3 Geriatric
6.4 Pediatric
7 Global Cholesterol Testing Products & Services Market, By Type of Customer
7.1 Introduction
7.2 Diagnostic Centers
7.3 Government Agencies
7.4 Physicians/Providers and Hospitals
8 Americas’ Cholesterol Testing Products & Services Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Cholesterol Testing Products & Services Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Cholesterol Testing Products & Services Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Cholesterol Testing Products & Services Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 IGR Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 Blooms The Chemist
13.3 Boston Heart Diagnostics Corp.
13.4 Bypass Pharmacy, Inc.
13.5 Cell Biolabs, Inc.
13.6 Eurofins Scientific SE
13.7 F. Hoffmann-La Roche Ag
13.8 Jant Pharmacal Corp.
13.9 Kays Medical, Ltd.
13.10 Laboratory Corp.
13.11 Merck KGaA
13.12 Portea Medical
13.13 Quest Diagnostics, Inc.
13.14 Randox Laboratories, Ltd.
13.15 Siemens Healthcare GmbH
13.16 Thermo Fisher Scientific, Inc.
13.17 Zoetis Services, LLC
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Blooms The Chemist
  • Boston Heart Diagnostics Corp.
  • Bypass Pharmacy, Inc.
  • Cell Biolabs, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ag
  • Jant Pharmacal Corp.
  • Kays Medical, Ltd.
  • Laboratory Corp.
  • Merck KGaA
  • Portea Medical
  • Quest Diagnostics, Inc.
  • Randox Laboratories, Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Zoetis Services, LLC